Related Experiment Video
Updated: Mar 29, 2026

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Medical Device Risk Management For Performance Assurance Optimization and Prioritization
Performance assurance (PA) in clinical engineering requires a unified framework. This study proposes a risk management framework and a general model to enhance medical device quality and PA program decision-making.
Area of Science:
- Clinical Engineering
- Biomedical Engineering
- Healthcare Technology Management
Background:
- Performance assurance (PA) is critical for medical device risk management within clinical engineering (CE).
- Existing efforts focus on defining risk factors and developing quantitative models for PA programs.
- A unified framework for quantitative risk systems in PA is currently lacking.
Purpose of the Study:
- To provide a perspective on medical device quality and risk-based elements of PA programs.
- To introduce a PA risk management framework.
- To propose a general model for quantitative risk systems.
Main Methods:
- Review of previous quantitative models for PA risk management.
- Development of a PA risk management framework.
- Proposal of a general model for quantitative risk systems.
Main Results:
- A PA risk management framework is presented.
- Previous quantitative models are examined.
- A general model for quantitative risk systems is proposed.
Conclusions:
- A common framework is needed for quantitative risk systems in PA.
- The proposed framework and model can improve medical device quality and PA program decision-making.
- Future directions in PA technology are discussed.
Related Concept Videos
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Mitral Valve Prolapse II: Assessment and Management
Rheumatic Heart Disease III: Medical Management
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

